This approach may be of particular interest for breast cancers that critically depend on the generation of ErbB-family growth factors via ADAM10 or ADAM17 not only in terms of cell migration and metastasis but also in terms of cell proliferation and tumor growth. This evidence concerns the gene ADAM17 and neoplasm.